Abstract:As an essential element, iron plays a central role in many physiological processes, including redox balance, inflammation, energy metabolism, and environment sensing. Perturbations in iron homeostasis are associated with several conditions, including hyperglycemia and diabetes, both of which have been studied in patients and animal models. To clarify the pleiotropic role of iron homeostasis in diabetes development, the early studies on diseases with iron-overload, studies on clinical iron depletion therapies, associations between iron-related genetic polymorphisms and diabetes, and etiological mechanisms underlying iron perturbations-impaired insulin secretion and insulin sensitivity were carefully reviewed and discussed. Hereditary hemochromatosis, transfusion-dependent thalassemia, and excess heme iron intake can increase the risk of developing diabetes. Genetically modified mice and mice fed a high-iron diet present with discrepant phenotypes due to differences in tissue iron distribution. Moreover, several genetic polymorphisms related to iron homeostasis have been associated with the risk of developing diabetes. Tightly controlled iron metabolism is essential for insulin secretion and insulin sensitivity, and iron overload in pancreatic islets alters reactive oxygen species (ROS) generation, as well as hypoxia-inducible factor-1α (HIF-1α) stability and adenosine triphosphate (ATP) synthesis, thereby impairing the function and viability of β-cells. Decreased levels of adiponectin, macrophage-mediated inflammation, and ROS-mediated liver kinase B1 (LKB1)/adenosine monophosphate-activated protein kinase (AMPK) activation can contribute to iron overload-induced insulin resistance, whereas iron deficiency could also participate in obesity-related inflammation, hypoxia, and insulin resistance. Because iron homeostasis is closely correlated with many metabolic processes, future studies are needed in order to elucidate the finely tuned network among iron homeostasis, carbohydrate and lipid metabolism, inflammation, and hypoxia.

Dietary Iron Modulates Hepatic Glucose Homeostasis Via Regulating Gluconeogenesis

Dietary Iron Controls Circadian Hepatic Glucose Metabolism Through Heme Synthesis

Dietary Iron Modulates Glucose and Lipid Homeostasis in Diabetic Mice

Regulation Of Glucose Homeostasis And Lipid Metabolism By Ppp1r3g-Mediated Hepatic Glycogenesis

High-iron Diet Damages Brown Adipose Tissue Mitochondria and Exacerbates Metabolic Hazards of a High-Fat Diet

Iron Overload Protects from Obesity by Ferroptosis

Regulation of a High-Iron Diet on Lipid Metabolism and Gut Microbiota in Mice

Iron Regulates Cellular Proliferation by Enhancing the Expression of Glucose Transporter GLUT3 in the Liver

Hepatic Iron Stores Are Increased As Assessed by Magnetic Resonance Imaging in a Chinese Population with Altered Glucose Homeostasis

Antagonizing Effects of Chromium Against Iron-Decreased Glucose Uptake by Regulating ROS-Mediated PI3K/Akt/GLUT4 Signaling Pathway in C2C12

Heme Oxygenase-1 Regulates Ferrous Iron and Foxo1 in Control of Hepatic Gluconeogenesis

A Low Iron Diet Protects from Steatohepatitis in a Mouse Model

Glucose induced regulation of iron transporters implicates kidney iron accumulation

Impaired Ferritinophagy Flux Induced by High Fat Diet Mediates Hepatic Insulin Resistance Via Endoplasmic Reticulum Stress.

Iron Increases Liver Injury Through Oxidative/Nitrative Stress in Diabetic Rats: Involvement of Nitrotyrosination of Glucokinase

[Effect of Iron Overload on Function of Pancreatic Beta Cells in Rats].

Iron supplementation and iron accumulation promote adipocyte thermogenesis through PGC1α-ATGL-mediated lipolysis

Iron overload induces islet β cell ferroptosis by activating ASK1/P-P38/CHOP signaling pathway

Effect of Iron Overload on Function of Pancreatic β Cells in Rats

Pleiotropic Actions of Iron Balance in Diabetes Mellitus

Iron Overload in Hypothalamic AgRP Neurons Contributes to Obesity and Related Metabolic Disorders